Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.01 | uM | 9 | 156.25 | 71.09 | 76.00 | 114.75 | 0.6623 | 0.1015 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 109.00 | 114.75 | 0.9499 | 0.8566 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 156.25 | 71.09 | 135.00 | 114.75 | 1.1765 | 1.5305 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 111.00 | 114.75 | 0.9673 | 0.9061 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 156.25 | 71.09 | 86.00 | 114.75 | 0.7495 | 0.3174 |
| BT-20 | Linsitinib | 1 | uM | 9 | 156.25 | 71.09 | 104.00 | 114.75 | 0.9063 | 0.7346 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 94.00 | 114.75 | 0.8192 | 0.4984 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 97.00 | 114.75 | 0.8453 | 0.5681 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 49.00 | 114.75 | 0.4270 | -0.4165 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 107.00 | 114.75 | 0.9325 | 0.8075 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 121.00 | 114.75 | 1.0545 | 1.1596 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 156.25 | 71.09 | 131.00 | 114.75 | 1.1416 | 1.4227 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 156.25 | 71.09 | 126.00 | 114.75 | 1.0980 | 1.2900 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 156.25 | 71.09 | 94.00 | 114.75 | 0.8192 | 0.4984 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 111.00 | 114.75 | 0.9673 | 0.9061 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 71.09 | 108.00 | 114.75 | 0.9412 | 0.8320 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 129.00 | 114.75 | 1.1242 | 1.3693 | |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 156.25 | 71.09 | 108.00 | 114.75 | 0.9412 | 0.8320 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 156.25 | 71.09 | 76.00 | 114.75 | 0.6623 | 0.1015 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 156.25 | 71.09 | 122.00 | 114.75 | 1.0632 | 1.1855 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 117.00 | 114.75 | 1.0196 | 1.0570 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 156.25 | 71.09 | 71.00 | 114.75 | 0.6187 | -0.0019 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 156.25 | 71.09 | 126.00 | 114.75 | 1.0980 | 1.2900 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 144.00 | 114.75 | 1.2549 | 1.7783 | |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 236.00 | 114.75 | 2.0566 | 4.6805 |